• Translation

    by Transposh - google translate and bing translate plugin for wordpress
 We apologize for not acceptable in some cases, the art of translation technology, but the view, a rough impression may be of use
we apologize for the sometimes poor quality of the automatic translation, but we believe, that even a rough idea of the contents might be helpful.

 

Title

ADVERTISEMENTS


Springer erwirbt BioMed Central Group

Springer Science Business Media (www.springer.com) has an agreement to acquire BioMed Central Group (www.biomedcentral.com), the world's leading open access publisher, getroffen.BioMed Central in May 2000 Founded as an independent publisher with the goal, offer free access to peer-reviewed research articles in biology and medicine. With more than 180 peer-reviewed journals BioMed Central is the world's largest open access provider. Some of the most important journals of the publishing house are Journal of Biology, BMC Biology, BMC Medicine, Malaria Journal, BMC Bioinformatics and Genome Biology. BioMed Central has revenues of approximately 15 Million € in. The publisher is based in London, with a second office in Liverpool, and employs approximately 150 Staff.

Derk Haank, CEO of Springer Science Business Media: "This acquisition reinforces the fact, that we consider open-access journals as a viable option in the scientific publishing, and not as an ideological campaign. We have been in the starting Springer Open Choice years 2004 significantly positive experiences gained, and the activities of BioMed Central are for us a perfect complement. In addition, we can expand with the purchase of the position of Springer in the life sciences and biomedical scientific societies and offer a greater range of publishing options.”

Matthew Cockerill, Publisher bei BioMed Central: "We are very excited about this new growth- and development phase of BioMed Central. The willingness of Springer, to experiment with open access publishing models, is exceptional among the major STM publishers. BioMed Central has shown, that Open Access can function as a business model, and we look forward to continued strong growth as part of Springer. The support of our authors, Magazine editor and institutional customers is critical to the success of BioMed Central, and we will continue to focus on, to offer them the best possible service.”

Springer Science Business Media (www.springer.com) is a leading international publisher of scientific- and literature. Springer is the second-largest publisher of journals in the STM (Science, Technology, Medicine), the largest publisher of STM books and in the German market leader in business-to-Business. The company brings over 1.700 Journals, more than 5.500 new books every year and the largest STM eBook Collection with up to date about 28.000 Titles published. Springer presented in 2004 Springer Open ChoiceTM (www.springer.com/openchoice) before, an open-access option for authors and institutions. With about 5.000 Employees, has operations in about 20 Countries in Europe, the U.S. and Asia. In 2007 generated annual sales of approximately. 906 Million €.

BioMed Central (www.biomedcentral.com) is a STM publisher and pioneer of the Open Access publishing model. All peer-reviewed research articles, BioMed Central publishes, are now freely available on the Internet and appear under a license, the further distribution and use permits.

Berlin / London, 7. October 2008

Contact:
Eric Merkel-Sobotta
Springer Science Business Media
Tel: +49 30 82 787 54 34
eric.merkel-sobotta@springer.com



Posted on 07.10.2008 in Verlagsnachrichten .

This page Konnen she mieten! - Present your company with effective text- and image advertising.. (Advertising Information)



-